Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03621826 · ClinicalTrials.gov registry record
Evaluating Barriers to Stroke Screening and Prevention in Children With Sickle Cell Disease
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 5,247
- Enrollment target
NCT03621826 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 5,247 participants.
The verdict
NCT03621826 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 5,247 participants
- Enrollment target
Study Summary
DISPLACE is a three part, multi-center U.S. based study to evaluate the barriers to stroke screening and prevention in children with sickle cell anemia (SCA). In the United States, TCD (Transcranial Doppler ultrasound) is a proven method of screening children with SCA for stroke. However, many children are not getting the screening they need. This study will examine the issues that hinder and help children get the screening at 28 different hospitals and sickle cell centers to improve care for all children with sickle cell anemia. The investigators will then plan a study (part 3) aimed to improve stroke screening and prevention in sickle cell anemia.
Interventions
- OTHER Questionnaire/Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,247 participants |
| Start Date | 2018-02-12 |
| Est. Completion | 2019-06-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03621826
The ClinicalTrials.gov registry entry for NCT03621826 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,247 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire/Interview is the first listed.
NCT03621826 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03621826 about?
NCT03621826 is a clinical study titled "Evaluating Barriers to Stroke Screening and Prevention in Children With Sickle Cell Disease". DISPLACE is a three part, multi-center U.S. based study to evaluate the barriers to stroke screening and prevention in children with sickle cell anemia (SCA). In the United States, TCD (Transcranial Doppler ultrasound) is a proven method of screening children with SCA for stroke. However, many child...
What is the current status of trial NCT03621826?
This trial is currently completed. The enrollment target is 5,247 participants. The study started on 2018-02-12. Estimated completion is 2019-06-28.
What interventions are being tested in trial NCT03621826?
The interventions under investigation include: Questionnaire/Interview (OTHER).
Who is sponsoring clinical trial NCT03621826?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.